Search Results - "Duffy, S.W."

CT screening for lung cancer: Is the evidence strong enough? by Field, J.K, Devaraj, A, Duffy, S.W, Baldwin, D.R

“…Highlights • Do we have sufficient evidence to implement lung cancer CT screening? • Focused on the level of readiness (red, amber, green) in twelve specific…”
Get full text

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial by Blamey, R.W, Bates, T, Chetty, U, Duffy, S.W, Ellis, I.O, George, D, Mallon, E, Mitchell, M.J, Monypenny, I, Morgan, D.A.L, Macmillan, R.D, Patnick, J, Pinder, S.E

“…Abstract Background The incidence of local recurrence (LR) after conservative surgery for early breast cancer without adjuvant therapy is unacceptably high…”
Get full text

Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods by Seigneurin, A, Labarère, J, Duffy, S.W, Colonna, M

“…Highlights • Accurate estimates of overdiagnosis using annual incidence rates require adjustment for lead time. • Two methods of adjustment for lead time were…”
Get full text

P117 The evaluation of the breast cancer screening programme in Western Siberia by Zakharova, N, Belaya, J, Duffy, S.W, Pyankin, S, Pestryakova, A

Get full text

A telephone reminder intervention to improve breast screening information and access by Offman, J, Myles, J, Ariyanayagam, S, Colorado, Z, Sharp, M, Cruice, M, North, B.V, Shiel, S, Baker, T, Jefferies, R, Binysh, K, Duffy, S.W

“…Abstract Objectives In the UK, women aged 50–70 are offered breast cancer screening every three years. Screening participation rates in London have been…”
Get full text

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening by Yen, M.-F., Tabár, L., Vitak, B., Smith, R.A., Chen, H.-H., Duffy, S.W.

“…The relevance of detection of ductal carcinoma in situ (DCIS) in a breast cancer screening programme, and the extent of overdiagnosis of non-progressive…”
Get full text

54 MyLungRisk calculator: a user-friendly, web-based questionnaire for risk prediction of lung cancer based on the validated Liverpool Lung Project model by Field, J.K, Niaz, A, Farley, J, Hodge, N, Raji, O.Y, Duffy, S.W, Marcus, M.W, Chen, Y

Get full text

3538 POSTER Current Results of the Breast Cancer Screening Programme After Four Years Implementation in Khanty-Mansiysky Autonomous Okrug – Ugra by Zakharova, N, Duffy, S.W, Mackay, J, Kotlyarov, E, Filimonov, A, Belousov, V

Get full text

The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease by Duffy, S.W., Tabar, L., Vitak, B., Day, N.E., Smith, R.A., Chen, H.H.T., Yen, M.F.A.

“…We aimed to quantify the benefits of detecting ductal carcinoma in situ (DCIS) and of downwards stage-shifting within invasive tumours in mammographic…”
Get full text

The Long-term Benefits of a Single Scan for Abdominal Aortic Aneurysm (AAA) at Age 65 by Scott, R.A.P., Vardulaki, K.A, Walker, N.M, Day, N.E., Duffy, S.W., Ashton, H.A.

“…Aim to investigate the efficacy of a single ultrasonic scan at age 65 to identify patients at risk from ruptured abdominal aortic aneurysm (AAA). Method a…”
Get full text

Strategy for power calculation for interactions: Application to a trial of interventions to improve uptake of bowel cancer screening by Brentnall, A.R, Duffy, S.W, Baio, G, Raine, R

“…Abstract Poorer postcodes within 5 regions in England have a lower response to bowel-cancer screening invitations than do richer postcodes. An extension of the…”
Get full text

81 The uniqueness of the United Kingdom Lung Cancer Screening trial (UKLS) – a population screening study by McRonald, F, Baldwin, D.R, Devaraj, A, Brain, K, Eisen, T, Holeman, J, Ledson, M, Screaton, N, Rintoul, R.C, Yadegarfar, G, Hands, C, Lifford, K, Whynes, D, Kerr, K.M, Page, R, Parmar, M, Weller, D, Williamson, P, Hansell, D, Duffy, S.W, Field, J.K

Get full text

Dietary effects on breast-cancer risk in Singapore by Lee, H P, Gourley, L, Duffy, S W, Estéve, J, Lee, J, Day, N E

“…It is suspected that diet influences the risk of getting breast cancer. A study of diet and breast cancer was done among 200 Singapore Chinese women with…”
Get more information

All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point by Tabar, L, Duffy, S W, Yen, M-F, Warwick, J, Vitak, B, Chen, H-H, Smith, R A

“…It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that…”
Get more information

O-2 Screen-detected versus symptomatic breast cancer is improved survival due to stage migration alone? by Wishart, G.C, Greenberg, D.C, Duffy, S.W, Brown, C.H, Purushotham, A.D

Get full text

Early detection of second breast cancers improves prognosis in breast cancer survivors by Houssami, N., Ciatto, S., Martinelli, F., Bonardi, R., Duffy, S.W.

“…The impact of early detection of second breast cancers in women who have survived a primary breast cancer is unknown. We examined the prognostic effect of…”
Get full text

Probabilities of progression of aortic aneurysms: estimates and implications for screening policy by Couto, E, Duffy, S W, Ashton, H A, Walker, N M, Myles, J P, Scott, R A P, Thompson, S G

“…Screening for abdominal aortic aneurysm, and intervention with elective repair, can reduce the incidence of aneurysmal rupture by a half. If a screening…”
Get more information

LBA44CASE FATALITY IN BREAST CANCER: RELATIVE EFFECT OF ATTENDANCE AT BREAST SCREENING AND CANCER TREATMENT by Massat, N.J., Tataru, D., Parmar, D., Sasieni, P.D., Duffy, S.W.

“…Abstract Aim: Invasive breast cancer is the second most common cause of cancer death among UK women. Although community breast screening has been shown to…”
Get full text

Case Fatality in Breast Cancer: Relative Effect of Attendance at Breast Screening and Cancer Treatment by Massat, N.J., Tataru, D., Parmar, D., Sasieni, P.D., Duffy, S.W.

Get full text

Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening by Soo, E., Edey, A.J., Mak, S.M., Moser, J., Mohammadi, S., Rodrigues, T., Duffy, S.W., Field, J.K., Baldwin, D.R., Nair, A., Devaraj, A.

“…•Volumetry is the preferred method to assess nodule size in lung cancer screening.•Volumetry application suitability for screening depends on the chosen…”
Get full text